|
|||||
|
|
Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial |
|
| Authors: | Matteson Eric L Aringer Martin Burmester Gerd R Mueller Heiko Moros Lizette Kolb Martin |
| Institution: | 1.Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA ;2.Rheumatology, Medicine III, University Medical Center & Faculty of Medicine, TU Dresden, Dresden, Germany ;3.Department of Rheumatology and Clinical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany ;4.Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany ;5.Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany ;6.Department of Medicine, McMaster University and St. Joseph’s Healthcare, Hamilton, Ontario, Canada ; |
| Abstract: | Clinical Rheumatology - Some patients with rheumatoid arthritis develop interstitial lung disease (RA-ILD) that develops into progressive pulmonary fibrosis. We assessed the efficacy and safety of... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |